Screening of drugs to treat 8p11 myeloproliferative syndrome using patient-derived induced pluripotent stem cells with fusion gene CEP110-FGFR1
使用患者来源的融合基因 CEP110-FGFR1 诱导性多能干细胞筛选治疗 8p11 骨髓增生性综合征的药物
期刊:PLoS One
影响因子:2.9
doi:10.1371/journal.pone.0120841
Shohei Yamamoto, Makoto Otsu, Emiko Matsuzaka, Chieko Konishi, Haruna Takagi, Sachiyo Hanada, Shinji Mochizuki, Hiromitsu Nakauchi, Kohzoh Imai, Kohichiro Tsuji, Yasuhiro Ebihara
